Metsera responds to Pfizer litigation amid competing acquisition bids

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026


Go back to Metsera responds to Pfizer litigation amid competing acquisition bids

Novo Nordisk earnings preview: Barclays and BofA weigh in

November 4, 2025 4:00 PM UTC

Barclays and Bank of America both expect Novo Nordisk's (NYSE: NVO) third-quarter results on November 5 to come broadly in line with expectations but warn the drugmaker could lower the upper end of its 2025 guidance as prescription trends soften.

Barclays analyst Yihan Li said the bank now models +10.9% FY25 topline CER growth (generally in-line with guidance... More